Advertisement

Cardiac Pharmacology

  • Jeff Clark
  • Brad Tilford
Chapter

Abstract

Pharmacologic therapy is fundamental to the treatment of cardiac emergencies in children. Unfortunately, as with most drug therapy in children, little data exists as to optimal application of therapeutic agents. Therefore, a sound understanding of developmental physiology and pharmacology is necessary. In this chapter, we offer a succinct review of developmental physiology and pharmacology relevant to drug therapy and a concise overview of the application of the most relevant drugs.

Keywords

Pharmacology Physiology Inotrope Vasopressor Vasodilator Antihypertensive Antiarrhythmic Diuretic 

References

  1. 1.
    Allen HD. Moss and Adams heart disease in infants, children, and adolescents: including the fetus and young adult, vol. 2. 8th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013.Google Scholar
  2. 2.
    Guyton AC, Hall JE. Textbook of medical physiology, vol. xxxv. 11th ed. Philadelphia: Elsevier Saunders; 2006. 1116 pGoogle Scholar
  3. 3.
    Katz AM, Smith VE. Regulation of myocardial function in the normal and diseased heart. Modification by inotropic drugs. Eur Heart J. 1982;3 Suppl D:11–8.PubMedGoogle Scholar
  4. 4.
    Ghali MGZ. Role of the medullary lateral tegmental field in sympathetic control. J Integr Neurosci. 2017;16(2):189–208.CrossRefGoogle Scholar
  5. 5.
    Cody RJ. The integrated effects of angiotensin II. Am J Cardiol. 1997;79(5A):9–11.CrossRefGoogle Scholar
  6. 6.
    Takayama Y, Costa KD, Covell JW. Contribution of laminar myofiber architecture to load-dependent changes in mechanics of LV myocardium. Am J Physiol Heart Circ Physiol. 2002;282(4):H1510–20.CrossRefGoogle Scholar
  7. 7.
    Adhyapak SM, Parachuri VR. Architecture of the left ventricle: insights for optimal surgical ventricular restoration. Heart Fail Rev. 2010;15(1):73–83.CrossRefGoogle Scholar
  8. 8.
    Robinson RB. Autonomic receptor--effector coupling during post-natal development. Cardiovasc Res. 1996;31 Spec No:E68–76.CrossRefGoogle Scholar
  9. 9.
    Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate. 2006;89(4):330–5.CrossRefGoogle Scholar
  10. 10.
    Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369(25):2462–3.PubMedGoogle Scholar
  11. 11.
    Kho TL, et al. Influence of dobutamine and dopamine on hemodynamics and plasma concentrations of noradrenaline and renin in patients with low cardiac output following acute myocardial infarction. Eur J Clin Pharmacol. 1980;18(3):213–7.CrossRefGoogle Scholar
  12. 12.
    Jaski BE, et al. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. J Clin Invest. 1985;75(2):643–9.CrossRefGoogle Scholar
  13. 13.
    Hoffman TM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003;107(7):996–1002.CrossRefGoogle Scholar
  14. 14.
    De Luca L, et al. Evidence-based use of levosimendan in different clinical settings. Eur Heart J. 2006;27(16):1908–20.CrossRefGoogle Scholar
  15. 15.
    Ignarro LJ, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218(3):739–49.PubMedGoogle Scholar
  16. 16.
    Overholt ED, et al. Usefulness of adenosine for arrhythmias in infants and children. Am J Cardiol. 1988;61(4):336–40.CrossRefGoogle Scholar
  17. 17.
    Reynolds RD, Gorczynski RJ, Quon CY. Pharmacology and pharmacokinetics of esmolol. J Clin Pharmacol. 1986;26 Suppl A:A3–A14.CrossRefGoogle Scholar
  18. 18.
    Singh BN. Amiodarone: historical development and pharmacologic profile. Am Heart J. 1983;106(4 Pt 2):788–97.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Critical Care Medicine, Department of PediatricsChildren’s Hospital of MichiganDetroitUSA
  2. 2.Wayne State University School of MedicineDetroitUSA

Personalised recommendations